Saito T, Takeda A, Hashimoto K, et al. Int J Chron Obstruct Pulmon Dis. 2015;10:2393–2404.On page 2395, right column, line 3, “Philadelphia, PA, USA” should have read “Hoechberg, Germany”.On page 2396, Figure 2 was incorrect. The corrected figure is shown.On page 2396, right column, line 1, “although FEV1 and FVC were not log transformed prior to analysis” should have read “although sRaw and sGaw were log transformed prior to analysis”.On page 2397, right column, Lung volumes section, line 5, “Statistical significance was observed for postdose RV immediately after dosing (time =0) on day 28 for SFC250 + TIO compared to TIO and SFC250 (Tables S3, S4). Improvements on day 28 were als...
Abstract: Tiotropium bromide (TIO), a long-acting anticholinergic bronchodilator, is now used world-...
Background/Purpose: To compare the efficacy and safety of tiotropium and ipratropium in patients wit...
Background: Limited data are available for the efficacy of triple therapy with two long-acting bronc...
Takefumi Saito,1 Akinori Takeda,2 Katsuji Hashimoto,3 Akihiro Kobayashi,4 Tomoyuki Hayamizu,5 Gerald...
Ichinose M, Nishimura M, Akimoto M, et al. Int J Chron Obstruct Pulmon Dis. 2018;13:2147–2156....
Efficacy and safety of tiotropium+olodaterol fixed-dose combination (FDC) compared with the mono-com...
Hashimoto S, Ikeuchi H, Murata S, Kitawaki T, Ikeda K, Banerji D. Int J Chron Obstruct Pulmon Dis. 2...
Perrone V, Sangiorgi D, Buda S, Degli Esposti L. Int J Chron Obstruct Pulmon Dis. 2016;11:2749&ndash...
SummaryBackgroundThe combination of tiotropium and fluticasone propionate/salmeterol (FSC) is common...
Damkjær M, Håkansson K, Kallemose T, Ulrik CS, Godtfredsen N. Int J Chron Obstruct Pulmo...
Tomohiro Tamura, Hiroaki Satoh Division of Respiratory Medicine, Mito Medical Center, University of...
Masakazu Ichinose,1 Masaharu Nishimura,2 Manabu Akimoto,3 Yasuhiro Kurotori,3 Yihua Zhao,4 Alberto d...
BACKGROUND: Limited data are available for the efficacy of triple therapy with two long-acting bro...
Masakazu Ichinose,1 Hiroyuki Taniguchi,2 Ayako Takizawa,3 Lars Grönke,4 Lazaro Loaiza,4 Florian...
Background: Clinical information on 24-h spirometric efficacy of combining tiotropium and salmeterol...
Abstract: Tiotropium bromide (TIO), a long-acting anticholinergic bronchodilator, is now used world-...
Background/Purpose: To compare the efficacy and safety of tiotropium and ipratropium in patients wit...
Background: Limited data are available for the efficacy of triple therapy with two long-acting bronc...
Takefumi Saito,1 Akinori Takeda,2 Katsuji Hashimoto,3 Akihiro Kobayashi,4 Tomoyuki Hayamizu,5 Gerald...
Ichinose M, Nishimura M, Akimoto M, et al. Int J Chron Obstruct Pulmon Dis. 2018;13:2147–2156....
Efficacy and safety of tiotropium+olodaterol fixed-dose combination (FDC) compared with the mono-com...
Hashimoto S, Ikeuchi H, Murata S, Kitawaki T, Ikeda K, Banerji D. Int J Chron Obstruct Pulmon Dis. 2...
Perrone V, Sangiorgi D, Buda S, Degli Esposti L. Int J Chron Obstruct Pulmon Dis. 2016;11:2749&ndash...
SummaryBackgroundThe combination of tiotropium and fluticasone propionate/salmeterol (FSC) is common...
Damkjær M, Håkansson K, Kallemose T, Ulrik CS, Godtfredsen N. Int J Chron Obstruct Pulmo...
Tomohiro Tamura, Hiroaki Satoh Division of Respiratory Medicine, Mito Medical Center, University of...
Masakazu Ichinose,1 Masaharu Nishimura,2 Manabu Akimoto,3 Yasuhiro Kurotori,3 Yihua Zhao,4 Alberto d...
BACKGROUND: Limited data are available for the efficacy of triple therapy with two long-acting bro...
Masakazu Ichinose,1 Hiroyuki Taniguchi,2 Ayako Takizawa,3 Lars Grönke,4 Lazaro Loaiza,4 Florian...
Background: Clinical information on 24-h spirometric efficacy of combining tiotropium and salmeterol...
Abstract: Tiotropium bromide (TIO), a long-acting anticholinergic bronchodilator, is now used world-...
Background/Purpose: To compare the efficacy and safety of tiotropium and ipratropium in patients wit...
Background: Limited data are available for the efficacy of triple therapy with two long-acting bronc...